Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 1;78(6):1499-1504.
doi: 10.1093/jac/dkad116.

A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus

Collaborators, Affiliations

A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus

Andrew Henderson et al. J Antimicrob Chemother. .

Abstract

Objectives: There is clinical uncertainty over the optimal treatment for penicillin-susceptible Staphylococcus aureus (PSSA) infections. Furthermore, there is concern that phenotypic penicillin susceptibility testing methods are not reliably able to detect some blaZ-positive S. aureus.

Methods: Nine S. aureus isolates, including six genetically diverse strains harbouring blaZ, were sent in triplicate to 34 participating laboratories from Australia (n = 14), New Zealand (n = 6), Canada (n = 12), Singapore (n = 1) and Israel (n = 1). We used blaZ PCR as the gold standard to assess susceptibility testing performance of CLSI (P10 disc) and EUCAST (P1 disc) methods. Very major errors (VMEs), major error (MEs) and categorical agreement were calculated.

Results: Twenty-two laboratories reported 593 results according to CLSI methodology (P10 disc). Nineteen laboratories reported 513 results according to the EUCAST (P1 disc) method. For CLSI laboratories, the categorical agreement and calculated VME and ME rates were 85% (508/593), 21% (84/396) and 1.5% (3/198), respectively. For EUCAST laboratories, the categorical agreement and calculated VME and ME rates were 93% (475/513), 11% (84/396) and 1% (3/198), respectively. Seven laboratories reported results for both methods, with VME rates of 24% for CLSI and 12% for EUCAST.

Conclusions: The EUCAST method with a P1 disc resulted in a lower VME rate compared with the CLSI methods with a P10 disc. These results should be considered in the context that among collections of PSSA isolates, as determined by automated MIC testing, less than 10% harbour blaZ. Furthermore, the clinical relevance of phenotypically susceptible, but blaZ-positive S. aureus, remains unclear.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Penicillin zone size (mm) distribution by method. The number of laboratory tests by diameter of zone size split and coloured by the isolates blaZ PCR result (detected—red; not detected—grey). (a) and (b) depict results using the EUCAST (P1 disc) and the CLSI (P10 disc) methods, respectively, with method breakpoints indicated by the dashed lines. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Figure 2.
Figure 2.
Overall laboratory penicillin confirmatory testing results showing aggregated zone diameter by isolate. Aggregated penicillin zone diameter (mm) box and whisker plot (median with 95% CI) for the nine isolates in triplicate labelled A to I on the x-axis. Boxes filled in red represent isolates that are blaZ PCR positive. (a) and (b) depict results using the EUCAST (P1 disc) and the CLSI (P10 disc) methods, respectively. The numbers above the triplicate groups indicate the percentages of correct results. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.

References

    1. Resman F, Thegerstrom J, Mansson Fet al. . The prevalence, population structure and screening test specificity of penicillin-susceptible Staphylococcus aureus bacteremia isolates in Malmo, Sweden. J Infect 2016; 73: 129–35. 10.1016/j.jinf.2016.05.011 - DOI - PubMed
    1. Crane JK. Resurgence of penicillin-susceptible Staphylococcus aureus at a hospital in New York State, USA. J Antimicrob Chemother 2014; 69: 280–1. 10.1093/jac/dkt317 - DOI - PubMed
    1. Hagstrand Aldman M, Skovby A, Påhlman LI. Penicillin-susceptible Staphylococcus aureus: susceptibility testing, resistance rates and outcome of infection. Infect Dis 2017; 49: 454–60. 10.1080/23744235.2017.1280617 - DOI - PubMed
    1. Jokinen E, Laine J, Huttunen Ret al. . Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia. Infect Dis 2018; 50: 52–8. 10.1080/23744235.2017.1405276 - DOI - PubMed
    1. Baddour LM, Wilson WR, Bayer ASet al. . Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 2015; 132: 1435–86. 10.1161/CIR.0000000000000296 - DOI - PubMed

Publication types